CCDC 2248014: Experimental Crystal Structure Determination
François Baur, David A. Beattie, David Beer, David Bentley et autres
0 citationsThe Cambridge Structural Database
Julia Hatto
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
22Publications signalées
372Citations signalées
0Affiliations récentes
Domaines associés
Asthma and respiratory diseasesReceptor Mechanisms and SignalingCrystallization and Solubility StudiesPhosphodiesterase function and regulationX-ray Diffraction in Crystallography
Publications récentes
CCDC 2190540: Experimental Crystal Structure Determination
Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres
0 citationsThe Cambridge Structural Database
CCDC 2190539: Experimental Crystal Structure Determination
Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres
0 citationsThe Cambridge Structural Database
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Darren Le Grand, Martin Gosling, Urs Baettig, Parmjit Bahra et autres
36 citationsJournal of Medicinal Chemistry
Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma”
David A. Sandham, Lucy Barker, Lyndon Brown, Zarin Brown et autres
1 citationACS Medicinal Chemistry Letters
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma
David A. Sandham, Lucy Barker, Lyndon Brown, Zarin Brown et autres
35 citationsACS Medicinal Chemistry Letters
Discovery of Fevipiprant (NVP-QAW039), a potent and selective CRTh2 receptor antagonist for treatment of allergic diseases
David A. Sandham, Lucy Barker, Lyndon Brown, Zarin Brown et autres
0 citations
CCDC 873054: Experimental Crystal Structure Determination
Neil J. Press, Roger Taylor, Joseph D. Fullerton, Pamela Tranter et autres
0 citationsThe Cambridge Structural Database
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Neil J. Press, Roger Taylor, Joseph D. Fullerton, Pamela Tranter et autres
20 citationsJournal of Medicinal Chemistry
Early Process Development of a Squaramide-Based CXCR2 Receptor Antagonist
Benjamin Martin, Xinzhong Lai, Urs Baettig, Eva Neumann et autres
9 citationsOrganic Process Research & Development
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist
Nicola Arnold, David T. Beattie, Michelle Bradley, Andrew Brearley et autres
2 citationsBioorganic & Medicinal Chemistry Letters
Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate
Neil J. Press, Roger Taylor, Joseph D. Fullerton, Pamela Tranter et autres
33 citationsJournal of Medicinal Chemistry
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.